This record was last updated December 15, 2025 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
Summary
Women who develop preeclampsia during pregnancy are four times more likely to develop cardiovascular disease later in life, even if they are otherwise healthy. The reason why this occurs may be related to lasting blood vessel damage after the pregnancy but there are currently no specific treatment strategies to prevent this disease progression. This study addresses this public health issue by examining whether starting low dose aspirin therapy after pregnancy is an effective treatment for lasting blood vessel damage in order to inform better clinical management of cardiovascular disease risk in women who have had preeclampsia.
Protocol Amendment History
2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-12-04; most recent amendment 2025-12-08.